SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea
· Delayed Price · Currency is KRW 107,400
+900 (0.85%)
At close: May 2, 2025, 3:30 PM KST
22.60% (1Y)
| Market Cap | 8.41T |
| Revenue (ttm) | 547.60B |
| Net Income (ttm) | 240.74B |
| Shares Out | 78.31M |
| EPS (ttm) | 3,074.04 |
| PE Ratio | 34.94 |
| Forward PE | 57.24 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 90,798 |
| Average Volume | 115,053 |
| Open | 106,000 |
| Previous Close | 106,500 |
| Day's Range | 105,300 - 108,600 |
| 52-Week Range | 72,600 - 130,000 |
| Beta | 0.94 |
| RSI | 57.38 |
| Earnings Date | May 9, 2025 |